amiodarone has been researched along with Nodular Goiter in 11 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone-induced thyrotoxicosis (AIT) develops in 3% of amiodarone-treated patients in North America." | 8.85 | Amiodarone-induced thyrotoxicosis: a review. ( Houlden, RL; Tsang, W, 2009) |
| "To report a case of amiodarone-induced thyrotoxicosis (AIT) concomitant with thyroid cancer in multinodular goiter (MNG)." | 7.78 | Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report. ( Akamizu, T; Inaba, H; Kobayashi, S; Komatsu, M; Suzuki, S; Takeda, T, 2012) |
| "A 64-year-old female with atrial fibrillation and nodular goiter progressed to overt thyrotoxicosis after receiving therapy with amiodarone 200 mg/day for less than 12 weeks." | 7.75 | Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter. ( Hsiao, SH; Huang, SM; Hung, HC; Liang, YL; Ou, HY; Peng, SL; Wu, TJ, 2009) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 7.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2)." | 7.74 | Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. ( Cianchetti, ME; Loy, M; Mariotti, S; Melis, A; Perra, E; Piga, M; Pinna, G; Serra, A, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 7.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
| "Amiodarone-induced thyrotoxicosis (AIT) occurs both in abnormal thyroid glands (nodular goiter, latent Graves' disease) (type I AIT) or in apparently normal thyroid glands (type II AIT)." | 7.69 | Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. ( Bartalena, L; Bartolozzi, C; Bogazzi, F; Brogioni, S; Burelli, A; Martino, E; Mazzeo, S; Vitti, P, 1997) |
| "Iodine-induced hyperthyroidism has been frequently described when iodine is introduced into an iodine-deficient area." | 7.67 | Five patients with iodine-induced hyperthyroidism. ( Braverman, LE; Mordes, JP; Rajatanavin, R; Safran, M; Stoller, WA, 1984) |
| "The off-label use of OCAs was reviewed for the management of neonatal and adult Graves' disease, subacute thyroiditis, amiodarone-induced thyroiditis (AIT), exogenous hyperthyroidism, toxic multinodular goiter (TMNG), thyrotropinoma, thyrotoxicosis during pregnancy, rapid pre-operative control of hyperthyroidism, and thyroid storm." | 4.90 | Review of oral cholecystographic agents for the management of hyperthyroidism. ( Kim, TY; Martinez, DS; Tyer, NM, 2014) |
| "Amiodarone-induced thyrotoxicosis (AIT) develops in 3% of amiodarone-treated patients in North America." | 4.85 | Amiodarone-induced thyrotoxicosis: a review. ( Houlden, RL; Tsang, W, 2009) |
| "To report a case of amiodarone-induced thyrotoxicosis (AIT) concomitant with thyroid cancer in multinodular goiter (MNG)." | 3.78 | Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report. ( Akamizu, T; Inaba, H; Kobayashi, S; Komatsu, M; Suzuki, S; Takeda, T, 2012) |
| "A 64-year-old female with atrial fibrillation and nodular goiter progressed to overt thyrotoxicosis after receiving therapy with amiodarone 200 mg/day for less than 12 weeks." | 3.75 | Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter. ( Hsiao, SH; Huang, SM; Hung, HC; Liang, YL; Ou, HY; Peng, SL; Wu, TJ, 2009) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 3.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2)." | 3.74 | Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. ( Cianchetti, ME; Loy, M; Mariotti, S; Melis, A; Perra, E; Piga, M; Pinna, G; Serra, A, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 3.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
| "Amiodarone-induced thyrotoxicosis (AIT) occurs both in abnormal thyroid glands (nodular goiter, latent Graves' disease) (type I AIT) or in apparently normal thyroid glands (type II AIT)." | 3.69 | Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. ( Bartalena, L; Bartolozzi, C; Bogazzi, F; Brogioni, S; Burelli, A; Martino, E; Mazzeo, S; Vitti, P, 1997) |
| "Iodine-induced hyperthyroidism has been frequently described when iodine is introduced into an iodine-deficient area." | 3.67 | Five patients with iodine-induced hyperthyroidism. ( Braverman, LE; Mordes, JP; Rajatanavin, R; Safran, M; Stoller, WA, 1984) |
| "Thyrotoxicosis is a common disorder, especially in women." | 2.48 | Thyrotoxicosis. ( Boelaert, K; Franklyn, JA, 2012) |
| "Thyrotoxicosis is a well defined clinical entity, determined by an increase of plasma levels of thyroid hormones (T3 and T4)." | 2.41 | [The management of thyrotoxicosis: a schematic approach]. ( Carapezzi, C; Corsello, SM; Papi, G, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tyer, NM | 1 |
| Kim, TY | 1 |
| Martinez, DS | 1 |
| Liang, YL | 1 |
| Huang, SM | 1 |
| Peng, SL | 1 |
| Hsiao, SH | 1 |
| Hung, HC | 1 |
| Ou, HY | 1 |
| Wu, TJ | 1 |
| Tsang, W | 1 |
| Houlden, RL | 1 |
| Inaba, H | 1 |
| Suzuki, S | 1 |
| Takeda, T | 1 |
| Kobayashi, S | 1 |
| Akamizu, T | 1 |
| Komatsu, M | 1 |
| Franklyn, JA | 1 |
| Boelaert, K | 1 |
| O'Sullivan, AJ | 1 |
| Lewis, M | 1 |
| Diamond, T | 1 |
| Berti, P | 1 |
| Materazzi, G | 1 |
| Bogazzi, F | 2 |
| Ambrosini, CE | 1 |
| Martino, E | 2 |
| Miccoli, P | 1 |
| Loy, M | 1 |
| Perra, E | 1 |
| Melis, A | 1 |
| Cianchetti, ME | 1 |
| Piga, M | 1 |
| Serra, A | 1 |
| Pinna, G | 1 |
| Mariotti, S | 1 |
| Rajatanavin, R | 1 |
| Safran, M | 1 |
| Stoller, WA | 1 |
| Mordes, JP | 1 |
| Braverman, LE | 1 |
| Bartalena, L | 1 |
| Brogioni, S | 1 |
| Mazzeo, S | 1 |
| Vitti, P | 1 |
| Burelli, A | 1 |
| Bartolozzi, C | 1 |
| Papi, G | 1 |
| Carapezzi, C | 1 |
| Corsello, SM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Open-label, Parallel-group Study to Explore the Efficacy of High-intensity Focused Ultrasound (HIFU) Versus Fixed-dose Radioiodine-131 in the Treatment of Relapsed Graves' Disease[NCT03013257] | 240 participants (Actual) | Interventional | 2017-04-25 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for amiodarone and Nodular Goiter
| Article | Year |
|---|---|
Review of oral cholecystographic agents for the management of hyperthyroidism.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Goiter, Nodular; Humans; Hyperthyroidism; Neoplas | 2014 |
Amiodarone-induced thyrotoxicosis: a review.
Topics: Amiodarone; Anti-Arrhythmia Agents; Goiter, Nodular; Graves Disease; Humans; Thyroiditis, Subacute; | 2009 |
Thyrotoxicosis.
Topics: Agranulocytosis; Amiodarone; Antithyroid Agents; Atrial Fibrillation; Autoimmune Diseases; Child; Ex | 2012 |
[The management of thyrotoxicosis: a schematic approach].
Topics: Adenoma; Adrenal Cortex Hormones; Adult; Aged; Amiodarone; Antithyroid Agents; Cardiovascular Diseas | 2002 |
7 other studies available for amiodarone and Nodular Goiter
| Article | Year |
|---|---|
Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Goiter, Nodular; Humans; Middle Aged; Thyrotoxicosis | 2009 |
Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Carcinoma; Carcinoma, Papillary; Goiter, Nodular; Humans; Male; | 2012 |
Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Goiter, Nodular; Graves Disease; Humans; Male | 2006 |
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.
Topics: Aged; Amiodarone; Anesthesia, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve B | 2007 |
Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Female; Goiter, Nodular; Graves D | 2007 |
Five patients with iodine-induced hyperthyroidism.
Topics: Adult; Amiodarone; Chlorobutanol; Coloring Agents; Coronary Artery Bypass; Drug Combinations; Female | 1984 |
Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
Topics: Adult; Aged; Amiodarone; Antithyroid Agents; Diagnosis, Differential; Female; Glucocorticoids; Goite | 1997 |